Vectura Group plc Results Beat View; Will Up R&D by 10%; Seeks New US Licensee For VR315

Dow Jones -- U.K. drug company Vectura Group PLC (VEC.LN) Monday said it is eager to sign up a new partner to help bring generic asthma medicine VR315 to market in the U.S.